GSK Plc shares slumped in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over whether the former heartburn treatment Zantac causes cancer.
GSK Plunges as Drugmaker Must Face Zantac Cases in DelawareChina’s CNGR Looks to Snap Up More Lithium Projects in ArgentinaMicrosoft Makes $3.
Energy Secretary calls for more nuclear power while celebrating US$35 billion Georgia reactorsThe Daily Chase: GDP comes in softer than expectedThe Daily Chase: Strong numbers from RBC, CIBC cap earnings from big banksCan AI-driven efficiencies address Canada's lagging economic productivity?The Daily Chase: Light trading day on holidays in U.S.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
GSK Faces Whistleblower Suit From Lab That Found Zantac RiskGSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the heartburn medication that the UK drugmaker invented and turned into a blockbuster.
Read more »
Delaware judge lets more than 70,000 Zantac lawsuits go forwardExplore stories from Atlantic Canada.
Read more »
Delaware judge lets more than 70,000 Zantac lawsuits go forwardExplore stories from Atlantic Canada.
Read more »
First Zantac Cancer Case to Go to Trial Ends in Win for DrugmakersDrugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in the first of thousands of such lawsuits to go to trial.
Read more »
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg NewsPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Read more »
Pfizer agrees to settle more than 10,000 Zantac lawsuits in U.S.: Bloomberg NewsPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Read more »